In a recent episode of "This Week in Virology" (TWiV), Dr. Daniel Griffin provided his weekly clinical update, delving into…
Read More

In a recent episode of "This Week in Virology" (TWiV), Dr. Daniel Griffin provided his weekly clinical update, delving into…
Read More
A comprehensive review of 17 clinical trials by the esteemed Cochrane organization has cast doubt on the clinically meaningful benefits…
Read More
For more than six decades, metformin has served as the cornerstone of pharmacological management for type 2 diabetes. Since its…
Read More
With genetic test spending under the microscope, CMS is asking labs to help shape future anti-fraud rules—before formal proposals are…
Read More
The Centers for Medicare and Medicaid Services (CMS) has initiated a critical dialogue with the clinical laboratory community, seeking direct…
Read More
For more than six decades, metformin has served as the foundational pharmacotherapy for the management of type 2 diabetes, a…
Read More
Novartis has entered into a definitive agreement to acquire Excellergy, a privately held biotechnology company specializing in the development of…
Read More
The Centers for Medicare and Medicaid Services (CMS) has embarked on a significant preemptive strike against healthcare fraud, initiating a…
Read More
In a recent clinical update featured on "This Week in Virology" (TWiV) episode 1290, Dr. Daniel Griffin provided a comprehensive…
Read More
In a significant breakthrough that could reshape the therapeutic landscape for one of the most aggressive and intractable brain cancers,…
Read More